Teleflex Incorporated (NYSE:TFX) Holdings Lowered by IFM Investors Pty Ltd

IFM Investors Pty Ltd trimmed its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,311 shares of the medical technology company’s stock after selling 377 shares during the quarter. IFM Investors Pty Ltd’s holdings in Teleflex were worth $2,055,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. International Assets Investment Management LLC grew its stake in shares of Teleflex by 29,127.3% in the 3rd quarter. International Assets Investment Management LLC now owns 3,215 shares of the medical technology company’s stock worth $795,000 after purchasing an additional 3,204 shares during the last quarter. Sequoia Financial Advisors LLC grew its stake in shares of Teleflex by 2.4% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 6,637 shares of the medical technology company’s stock worth $1,641,000 after purchasing an additional 153 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Teleflex by 41.5% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company’s stock worth $6,010,000 after purchasing an additional 7,132 shares during the last quarter. Cadent Capital Advisors LLC grew its stake in shares of Teleflex by 23.4% in the 3rd quarter. Cadent Capital Advisors LLC now owns 1,674 shares of the medical technology company’s stock worth $414,000 after purchasing an additional 317 shares during the last quarter. Finally, Blue Trust Inc. grew its stake in shares of Teleflex by 47.2% in the 3rd quarter. Blue Trust Inc. now owns 312 shares of the medical technology company’s stock worth $77,000 after purchasing an additional 100 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Stephens lifted their price objective on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. Royal Bank of Canada lifted their price objective on shares of Teleflex from $260.00 to $275.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Truist Financial lifted their price objective on shares of Teleflex from $247.00 to $255.00 and gave the stock a “hold” rating in a research note on Monday, October 14th. Finally, Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $205.00 to $245.00 in a research report on Monday, July 1st. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $268.86.

Teleflex Stock Performance

Teleflex stock opened at $233.63 on Monday. The firm’s 50 day simple moving average is $241.03 and its 200-day simple moving average is $223.68. The company has a market cap of $11.00 billion, a P/E ratio of 37.50, a price-to-earnings-growth ratio of 2.15 and a beta of 1.16. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.58 and a quick ratio of 1.44. Teleflex Incorporated has a fifty-two week low of $177.63 and a fifty-two week high of $257.85.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.09. The firm had revenue of $749.70 million for the quarter, compared to analyst estimates of $762.98 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The company’s revenue for the quarter was up .9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.41 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 13.97 EPS for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Thursday, August 15th were paid a $0.34 dividend. The ex-dividend date was Thursday, August 15th. This represents a $1.36 annualized dividend and a yield of 0.58%. Teleflex’s dividend payout ratio is presently 21.83%.

Insider Buying and Selling at Teleflex

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the transaction, the director now owns 5,496 shares in the company, valued at approximately $1,313,159.28. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.43% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.